BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1701292)

  • 1. Aminergic metabolites in cerebrospinal fluid of humans previously exposed to MDMA: preliminary observations.
    Ricaurte GA; Finnegan KT; Irwin I; Langston JW
    Ann N Y Acad Sci; 1990; 600():699-708; discussion 708-10. PubMed ID: 1701292
    [No Abstract]   [Full Text] [Related]  

  • 2. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders.
    Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N
    Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380
    [No Abstract]   [Full Text] [Related]  

  • 3. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women.
    Wode-Helgodt B; Sedvall G
    Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302
    [No Abstract]   [Full Text] [Related]  

  • 4. Amine metabolites in cerebrospinal fluid from Huntigton's chorea patients treated with lithium.
    Vestergaard P; Yates CM
    Clin Chim Acta; 1978 Jul; 87(2):297-9. PubMed ID: 148982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amine metabolites in cerebrospinal fluids and thyrotropin releasing hormone in spinocerebellar degeneration].
    Arai M
    Rinsho Shinkeigaku; 1988 Jun; 28(6):595-604. PubMed ID: 2466598
    [No Abstract]   [Full Text] [Related]  

  • 6. Amine metabolites in the cerebrospinal fluid as a measure of central neurotransmitter function: methodological aspects.
    Bertilsson L; Asberg M
    Adv Biochem Psychopharmacol; 1984; 39():27-34. PubMed ID: 6205559
    [No Abstract]   [Full Text] [Related]  

  • 7. Possible interaction between an MAOI and "ecstasy".
    Kaskey GB
    Am J Psychiatry; 1992 Mar; 149(3):411-2. PubMed ID: 1346952
    [No Abstract]   [Full Text] [Related]  

  • 8. The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patients.
    Prell GD; Green JP; Elkashef AM; Khandelwal JK; Linnoila M; Wyatt RJ; Lawson WB; Jaeger AC; Kaufmann CA; Kirch DG
    Schizophr Res; 1996 May; 19(2-3):171-6. PubMed ID: 8789915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid measurements suggest precursor availability and sex are involved in the control of biogenic amine metabolism in a primate.
    Young SN; Ervin FR
    J Neurochem; 1984 Jun; 42(6):1570-3. PubMed ID: 6202838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CSF monoamine metabolites, depression, and suicide.
    Asberg M; Bertilsson L; Mårtensson B
    Adv Biochem Psychopharmacol; 1984; 39():87-97. PubMed ID: 6205566
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous determination of the three major monoamine metabolites in CSF by HPLC with electrochemical detection.
    Van Bockstaele M; Dillen L; Claeys M; De Potter WP
    Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):304-5. PubMed ID: 6187306
    [No Abstract]   [Full Text] [Related]  

  • 12. Genetic studies of CSF monoamine metabolites.
    Sedvall G; Iselius L; Nybäck H; Oreland L; Oxenstierna G; Ross SB; Wiesel FA
    Adv Biochem Psychopharmacol; 1984; 39():79-85. PubMed ID: 6205565
    [No Abstract]   [Full Text] [Related]  

  • 13. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M
    Essays Biochem; 1991; 26():77-87. PubMed ID: 1685707
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoamine interactions in narcolepsy and hypersomnia: a preliminary report.
    Faull KF; Thiemann S; King RJ; Guilleminault C
    Sleep; 1986; 9(1 Pt 2):246-9. PubMed ID: 2422716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ; Kehne JH
    Ann N Y Acad Sci; 1990; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract]   [Full Text] [Related]  

  • 16. Cerebrospinal fluid transmitter metabolites and atmospheric pressure.
    Nordin C; Eklundh T
    Biol Psychiatry; 1996 Oct; 40(7):682-4. PubMed ID: 8886306
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous determination of the three major monoamine metabolites in cerebrospinal fluid by high-performance liquid chromatography with electrochemical detection.
    Van Bockstaele M; Dillen L; Claeys M; De Potter WP
    J Chromatogr; 1983 Jun; 275(1):11-20. PubMed ID: 6192136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid monoamine metabolites and atmospheric pressure.
    Heilig M; Månsson JE; Blennow K
    Biol Psychiatry; 1996 Feb; 39(4):299-301. PubMed ID: 8645778
    [No Abstract]   [Full Text] [Related]  

  • 19. Serotonin neurotoxicity after (+/-)3,4-methylenedioxymethamphetamine (MDMA; "Ecstasy"): a controlled study in humans.
    McCann UD; Ridenour A; Shaham Y; Ricaurte GA
    Neuropsychopharmacology; 1994 Apr; 10(2):129-38. PubMed ID: 7517677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid amino acid and monoamine metabolite levels of Papio papio: correlation with photosensitivity.
    Lloyd KG; Scatton B; Voltz C; Bryere P; Valin A; Naquet R
    Brain Res; 1986 Jan; 363(2):390-4. PubMed ID: 2417669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.